These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Degree of sex differentiation of genetic female chicken treated with different doses of an aromatase inhibitor.
    Author: Yang X, Zheng J, Na R, Li J, Xu G, Qu L, Yang N.
    Journal: Sex Dev; 2008; 2(6):309-15. PubMed ID: 19276633.
    Abstract:
    Injection of an aromatase inhibitor before gonadal sex differentiation can induce female-to-male sex reversal in chicken, but a higher dose could reduce hatchability. In the present study, the dosage effect of Fadrozole, a nonsteroidal aromatase inhibitor, on gonadal differentiation was analyzed in sex-reversed genetic female chicken. There was no significant difference for the hatchability among low-dose (0.1, 0.3 and 0.5 mg) Fadrozole-injected groups and control groups (p > 0.05), but in high-dose groups (1.0 mg and 1.3 mg) the hatchability was significantly reduced (p < 0.05). Complete phenotypic sex reversal was observed in both high- and low- dose groups, with more than 90% of genetic females reversed into phenotypic male chicks. The degree of gonadal differentiation in 124 chicken at 30 weeks of age was classified into 5 categories according to the visual appearance and histological structure of the gonads. Category I and V were standard ovary and testis, respectively, while category II, III, and IV represented gonads of slightly, moderately, and highly sex-reversed females, respectively. Most gonads in low-dose groups were classified into category I, II, and III, while those in high-dose groups were mainly category IV. The serum testosterone levels in the 1.3 mg group were significantly higher and the estradiol levels lower than those in low-dose groups (p < 0.05). In conclusion, the range from 0.5 to 1.0 mg Fadrozole is a key interval for survival of chicken embryos. The gonadal differentiation in sex-reversed females at 30 weeks of age is highly dependent on the dose of Fadrozole injected prior to gonadal sex differentiation.
    [Abstract] [Full Text] [Related] [New Search]